Compositions and methods for activating 'stimulator of interferon gene'-dependent signalling
The present invention provides highly active cyclic-di-nucleotide (CDN) immune stimulators that activate DCs via a recently discovered cytoplasmic receptor known as STING (Stimulator of Interferon Genes). In particular, the CDNs of the present invention are provided in the form of a composition comp...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
06.01.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides highly active cyclic-di-nucleotide (CDN) immune stimulators that activate DCs via a recently discovered cytoplasmic receptor known as STING (Stimulator of Interferon Genes). In particular, the CDNs of the present invention are provided in the form of a composition comprising one or more cyclic purine dinucleotides induce STING-dependent type I interferon production, wherein the cyclic purine dinuclotides present in the composition are substantially pure 2', 5', 2', 5' and 2', 5 ',3 ',5' CDNs, and prefereably Rp,Rp stereosiomers thereof. |
---|---|
Bibliography: | Application Number: CN201480028654 |